J.Safra Asset Management Corp Acquires 240,415 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

J.Safra Asset Management Corp raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 461.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 292,502 shares of the exchange traded fund’s stock after buying an additional 240,415 shares during the quarter. SPDR S&P Biotech ETF comprises approximately 2.1% of J.Safra Asset Management Corp’s holdings, making the stock its 14th largest position. J.Safra Asset Management Corp owned about 0.38% of SPDR S&P Biotech ETF worth $26,293,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of XBI. Golden State Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $29,000. Avior Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC lifted its position in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares in the last quarter. Finally, Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $40,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $86.13 on Wednesday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The business has a 50 day simple moving average of $90.76 and a two-hundred day simple moving average of $95.58. The stock has a market capitalization of $5.68 billion, a PE ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.